Combination Osilodrostat and Cabergoline in Cushing's Disease | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Combination Osilodrostat and Cabergoline in Cushing's Disease	46,XX disorder of sex development, ACTH-dependent Cushing syndrome, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Hyperandrogenism, Male Urogenital Diseases, Nutritional and Metabolic Diseases, Urogenital Abnormalities, Urogenital Diseases, Water-Electrolyte Imbalance, adrenal gland disorder, adrenocortical insufficiency, adrenogenital syndrome, brain disorder, cardiovascular disorder, central nervous system disorder, disorder of sexual differentiation, endocrine system disorder, gonadal disorder, hyperpituitarism, hypertensive disorder, hypothalamic disorder, metabolic disease, nervous system disorder, pituitary gland disorder, potassium deficiency disease, vascular disorder	Enrolling by invitation	Phase 4	2026-05-22		NCT07603466

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
University of Basrah	5

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Al-Hassan Metabolism Endocrine and Diabetes Center	Karbala	Iraq	1
Al-Waffa Specialized Center for Diabetes and Endocrinology	Mosul	Iraq	1
Faiha Specialized Diabetes, Endocrine, and Metabolism Center	Basra	Iraq	1
Najaf Specialized Diabetes and Endocrine Center	Najaf	Iraq	1
Thi-Qar Specialized Diabetes, Endocrine and Metabolism Center	Nasiriyah	Iraq	1